About this trial
The aim of this study is to determine the usability of echocardiographic PAP changes obtained from emergency department records in the early risk stratification of pulmonary embolism.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Presenting to the emergency department with dyspnea between the specified dates,
Being 18 years of age or older,
Being evaluated in the emergency department with a preliminary diagnosis of pulmonary embolism,
Having a recorded pulmonary artery pressure measurement at the time of hospital admission,
Disqualifiers
Patients under 18 years of age,
Lack of pulmonary artery pressure data from the time of emergency admission or from the previous period,
Lack of necessary clinical, laboratory, or imaging data for pulmonary embolism evaluation,
In cases of repeated admissions for the same patient, only the first suitable admission will be considered; other admissions will be excluded from the study,
Trial population
Patients aged 18 and over who present to the emergency department with dyspnea between the specified study dates, are diagnosed with pulmonary embolism, have had their pulmonary artery pressure measured, have a previous pulmonary artery pressure measurement in their patient records, and have complete clinical, laboratory, imaging, and echocardiography data will be included in the study.
Trial design
Case-only
Retrospective
Treatments tested in this trial
Pulmonary embolism (+)
Other interventionpatients diagnosed with pulmonary embolism who have previously had their pulmonary artery pressure measured
pulmonary embolism (-)
Other interventioncontrol group
Treatment groups
Trial outcomes
Primary outcomes
pulmonary artery pressure
The difference between the pulmonary artery pressure measured in the previous echocardiogram and the pulmonary artery pressure at the time of admission to the emergency department.
Secondary outcomes
the relationship between pulmonary embolism and comorbidity
The relationship between the degree of increase in pulmonary artery pressure and pulmonary embolism in patients with COPD and heart failure.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: